Edition:
United Kingdom

Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

138.71USD
8:22pm BST
Change (% chg)

$0.59 (+0.43%)
Prev Close
$138.12
Open
$138.35
Day's High
$138.87
Day's Low
$137.49
Volume
494,475
Avg. Vol
2,006,142
52-wk High
$148.97
52-wk Low
$118.62

Select another date:

Sun, May 19 2019

Photo

Modi’s jobs deficit: J&J’s largest India plant idle three years after completion

PENJERLA/NEW DELHI, India It was supposed to be Johnson & Johnson's biggest manufacturing plant in India. It was to eventually employ at least 1,500 people and help bring development to a rural area near Hyderabad in southern India.

Modi’s jobs deficit - J&J’s largest India plant idle three years after completion

PENJERLA/NEW DELHI, India It was supposed to be Johnson & Johnson's biggest manufacturing plant in India. It was to eventually employ at least 1,500 people and help bring development to a rural area near Hyderabad in southern India.

INSIGHT-Modi’s jobs deficit: J&J’s largest India plant idle 3 years after completion

* The plant was completed in 2016 but has been idle ever since

U.S. FDA labels J&J surgical staplers' recall as severest

The U.S. Food and Drug Administration warned of risks of serious injury or death from surgical staplers made by Johnson & Johnson's Ethicon unit, labeling a recent recall of the device as its most serious.

UPDATE 2-U.S. FDA labels J&J surgical staplers' recall as severest

May 17 The U.S. Food and Drug Administration warned of risks of serious injury or death from surgical staplers made by Johnson & Johnson's Ethicon unit, labeling a recent recall of the device as its most serious.

FDA issues recall of J&J unit Ethicon's surgical staplers

May 17 The U.S. Food and Drug Administration on Friday issued a recall of surgical staplers made by Johnson & Johnson's Ethicon unit, warning that the use of the devices could cause serious injury or death.

Johnson & Johnson to submit applications for at least 10 new drugs by 2023

Johnson & Johnson said on Wednesday it expected to file marketing applications for at least 10 new drugs between 2019 to 2023, to strengthen its pharmaceuticals unit which has been a major growth driver.

Johnson & Johnson to submit applications for at least 10 new drugs by 2023

May 15 Johnson & Johnson said on Wednesday it expected to file marketing applications for at least 10 new drugs between 2019 to 2023, to strengthen its pharmaceuticals unit which has been a major growth driver.

Danish medical equipment maker Ambu sinks after departure of CEO

COPENHAGEN, May 10 Shares in Danish medical device maker Ambu slumped more than 10 percent on Friday after it surprisingly replaced its chief executive with a new boss hired from Johnson & Johnson.

J&J agrees to pay about $1 billion to resolve hip implant lawsuits: Bloomberg

Johnson & Johnson agreed to pay about $1 billion to resolve the bulk of lawsuits claiming the company sold defective metal-on-metal hip implants that ultimately had to be removed, Bloomberg reported on Tuesday, citing people with knowledge of the matter.

Select another date: